HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Friedheim, E. A. H. Search for Related Content PubMed Articles by Friedheim, E. A. H.

Mel B in the Treatment of Human Trypanosomiasis^1,2,

1) "Mel B," a new trivalent arsenical has been applied to the treatment of 50 cases of human second stage T. gambiense Sleeping Sickness, of which 20 cases presented trypanosomes in the CSF.

2) The cases have been controlled up to 7 months after the treatment.

3) The treatment had no untoward effect.

4) The trypanosomes disappeared in all cases without reoccurrence from lymph glands and blood, 24 hours after the first injection.

5) "Mel B" penetrates into the CSF and exerts a strong parasiticidal effect on the trypanosomes in the central nervous system.

6) A single series of 3–4 daily injections of "Mel B", i.e. a treatment of 3–4 days duration, may restore the pathological CSF changes of advanced meningoencephalitis Sleeping Sickness cases to normal co-incident with clinical recovery.

¹ From the laboratory of Ernst A. H. Friedheim, 333 West 52nd St., New York 19, N. Y.

² In collaboration with the Sleeping Sickness Service of French West Africa.